These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12466531)

  • 21. Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases.
    Klemm M; Cheng C; Cassell G; Shuman S; Segall AM
    J Mol Biol; 2000 Jun; 299(5):1203-16. PubMed ID: 10873446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA topoisomerases as repair enzymes: mechanism(s) of action and regulation by p53.
    Larsen AK; Gobert C; Gilbert C; Markovits J; Bojanowski K; Skladanowski A
    Acta Biochim Pol; 1998; 45(2):535-44. PubMed ID: 9821882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human topoisomerase I damage response plays a role in apoptosis.
    Søe K; Rockstroh A; Schache P; Grosse F
    DNA Repair (Amst); 2004 Apr; 3(4):387-93. PubMed ID: 15010314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination.
    Bullock P; Champoux JJ; Botchan M
    Science; 1985 Nov; 230(4728):954-8. PubMed ID: 2997924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human DNA topoisomerase I: relaxation, roles, and damage control.
    Leppard JB; Champoux JJ
    Chromosoma; 2005 Jul; 114(2):75-85. PubMed ID: 15830206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How do drug-induced topoisomerase I-DNA lesions signal to the molecular interaction network that regulates cell cycle checkpoints, DNA replication, and DNA repair?
    Kohn KW; Shao RG; Pommier Y
    Cell Biochem Biophys; 2000; 33(2):175-80. PubMed ID: 11325037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of DNA topoisomerase I activity by p53.
    Gobert C; Bracco L; Rossi F; Olivier M; Tazi J; Lavelle F; Larsen AK; Riou JF
    Biochemistry; 1996 May; 35(18):5778-86. PubMed ID: 8639538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model for topoisomerase I-mediated insertions and deletions with duplex DNA substrates containing branches, nicks, and gaps.
    Henningfeld KA; Hecht SM
    Biochemistry; 1995 May; 34(18):6120-9. PubMed ID: 7742316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deciphering the distinct role for the metal coordination motif in the catalytic activity of Mycobacterium smegmatis topoisomerase I.
    Bhat AG; Leelaram MN; Hegde SM; Nagaraja V
    J Mol Biol; 2009 Nov; 393(4):788-802. PubMed ID: 19733176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.
    Tomicic MT; Christmann M; Kaina B
    Cancer Res; 2005 Oct; 65(19):8920-6. PubMed ID: 16204064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topoisomerase I-DNA covalent complexes in human colorectal cancer xenografts with different p53 and microsatellite instability status: relation with their sensitivity to CTP-11.
    Lansiaux A; Bras-Goncalves RA; Rosty C; Laurent-Puig P; Poupon MF; Bailly C
    Anticancer Res; 2001; 21(1A):471-6. PubMed ID: 11299781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Error-free and mutagenic processing of topoisomerase 1-provoked damage at genomic ribonucleotides.
    Sparks JL; Burgers PM
    EMBO J; 2015 May; 34(9):1259-69. PubMed ID: 25777529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the interaction between topoisomerase II and DNA by transcriptional footprinting.
    Thomsen B; Bendixen C; Lund K; Andersen AH; Sørensen BS; Westergaard O
    J Mol Biol; 1990 Sep; 215(2):237-44. PubMed ID: 2170662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA Damage-Response Pathway Heterogeneity of Human Lung Cancer A549 and H1299 Cells Determines Sensitivity to 8-Chloro-Adenosine.
    Yang SY; Li Y; An GS; Ni JH; Jia HT; Li SY
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple endonucleases function to repair covalent topoisomerase I complexes in Saccharomyces cerevisiae.
    Deng C; Brown JA; You D; Brown JM
    Genetics; 2005 Jun; 170(2):591-600. PubMed ID: 15834151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleosomes represent a physical barrier for cleavage activity of DNA topoisomerase I in vivo.
    Di Felice F; Chiani F; Camilloni G
    Biochem J; 2008 Feb; 409(3):651-6. PubMed ID: 17967163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks.
    Sabourin M; Nitiss JL; Nitiss KC; Tatebayashi K; Ikeda H; Osheroff N
    Nucleic Acids Res; 2003 Aug; 31(15):4373-84. PubMed ID: 12888496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins.
    El-Hizawi S; Lagowski JP; Kulesz-Martin M; Albor A
    Cancer Res; 2002 Jun; 62(11):3264-70. PubMed ID: 12036943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Camptothecins inhibit the utilization of hydrogen peroxide in the ligation step of topoisomerase I catalysis.
    Lisby M; Krogh BO; Boege F; Westergaard O; Knudsen BR
    Biochemistry; 1998 Jul; 37(30):10815-27. PubMed ID: 9692972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing T lymphocytes are uniquely sensitive to a lack of topoisomerase III alpha.
    Mönnich M; Hess I; Wiest W; Bachrati C; Hickson ID; Schorpp M; Boehm T
    Eur J Immunol; 2010 Sep; 40(9):2379-84. PubMed ID: 20623552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.